8 Invivoscribe 2019 | 9 8 Partnerships We support partnerships worldwide to develop, validate, and commercialize molecular assays and reagents. Our global distribution network operates in more than 700 laboratories in over 160 countries. Quality Internationally harmonized diagnostics. We follow full QSR design control for assay and software development. Products are manufactured under cGMP and ISO 13485. Our global network of Laboratories for Personalized Molecular Medicine are CLIA/CAP accredited, ISO 15189 certified, and New York State licensed in the US. Germany is ISO 15189/DAkkS certified. Our new clinical lab in Japan opened Summer 2016. A Full Range of Collaborators We work with with a full range of key opinion leaders; leading healthcare institutions; top-tier pharmaceutical companies; and, most importantly, patients seeking to better understand their individual disease when they include their physicians in the dialogue. Global Reach The Invivoscribe portfolio of cGMP products are currently being used by more than 700 clinical and research laboratories across 160 countries worldwide. 700 Laboratory Customers 160 Countries Worldwide